Accenture PLC Receives High Marks from Investment Gurus

Accenture PLC (ACN) stands out with a commendable 86% score from the Patient Investor model based on Warren Buffett's principles. This high rating indicates strong potential interest for investors seeking long-term, stable growth.

Date: 09-03-2025

AI Rating: 7

**Earnings Predictability and Financial Health**
According to the report, Accenture PLC (ACN) demonstrates strong characteristics as per the Patient Investor model. The stock has passed multiple metrics significant for assessing financial health. Noteworthy is the report's highlight that Earnings Predictability, Debt Service, Return on Equity (ROE), Free Cash Flow (FCF), and other important ratios have all scored positively. This indicates that ACN is viewed as a reliable and stable growth stock.

**Return on Equity (ROE)**
Accenture's Return on Equity is reported to be strong. High ROE is a positive indicator as it reflects how efficiently a company is using shareholder equity to generate profits. This might enhance investor confidence as it suggests effective management and business strategies.

**Free Cash Flow (FCF)**
ACN also scored well in the Free Cash Flow category. High free cash flow is essential for growth companies as it permits reinvestment in the business, payment of dividends, and debt reduction, which may further increase stock price in the long run.

In conclusion, the strong scores across various key financial parameters signal that ACN is on a strong footing, potentially making it an appealing choice for investors focused on long-term growth based on value investing principles and the philosophy of investment legends like Warren Buffett.

Stocks: ACN